In the US trials the miracle cure COVID 19 showed bad results

Robert Redfield, Director of the Center for control and prevention (CDC), the United States stated that the drug used in the treatment of malaria, often advertised trump showed “poor results” during its use by patients in hospitals for American veterans.

the Researchers said that among patients who were given hydroxychloroquine, there were more deaths than among those who received standard care or taking an antibiotic azithromycin, The Guardian reports.

the Researchers analyzed the medical records of 368 of male veterans hospitalized with confirmed coronavirus infection who died or were discharged by 11 April. About 28% who were given hydroxychloroquine, died, compared with 11% of those who received only usual care. About 22% of those who received this drug plus azithromycin, also died, but experts do not exclude other factors that could affect mortality. While 39% of veterans had survived and was discharged from the hospital.

the US President has repeatedly touted this drug during their daily briefings, and Management on sanitary inspection behind quality of foodstuff and medicines (FDA) has granted emergency authorization for the use of hydroxychloroquine for use on patients with coronavirus in some cases. But the FDA, observers say, has not conducted clinical trials to establish whether a drug is effective treatment for COVID-19.

Immediately after the opening of trump, who said about the usefulness of this medicine, Director of the National Institute of Allergy and infectious diseases of the United States, the chief specialist of the coronavirus in the White house Anthony Fauci called given by the President of the evidence “at best anecdotal”. According to him, there is still no credible evidence that hydroxychloroquine may be effective against COVID-19.

we will Remind that last week in Brazil, ended the study of action of hydroxychloroquine in the coronavirus in connection with the fact that 11 participants in the experiment died after his admission. Of the 81 volunteers who agreed to participate in the study, 41 received high doses of the drug. Three days later, those who received the highest dose, was observed for cardiac arrhythmias or irregular heart rate. Even three days after the initial heart rhythm disorders 11 volunteers died.